The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis

The aim of this study was to determine whether the protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism confers susceptibility to rheumatoid arthritis (RA) in populations with different ethnicities. MEDLINE database and manual search were utilized to identify articles in which the PTPN22 polymorphism was determined in RA patients and controls. A meta-analysis was conducted on the associations between the PTPN22 C1858T polymorphism and RA using (1) allelic contrast and (2) dominant model. A total of 30 separate comparisons involving 17,961 RA patients and 18,611 controls were considered in this meta-analysis. Meta-analysis showed an association between the T allele and RA in all subjects (OR = 1.490, 95 % CI = 1.332–1.668, P < 1.0 × 10−9). After stratification by ethnicity, analysis indicated that the T allele was significantly associated with RA in Europeans and in Non-Europeans (OR = 1.423, 95 % CI = 1.260–1.605, P = 1.0 × 10−8; OR = 1.902, 95 % CI = 1.488–2.430, P = 2.8 × 10−8). Meta-analysis of the CT + TT genotype showed the same result patterns as that shown by the PTPN22 C1858T polymorphism T allele. Furthermore, a direct comparison between rheumatoid factor (RF)-positive and RF-negative subjects revealed a significant association with the T allele in RA patients with RF, but not in subjects without RF (OR = 1.561, 95 % CI = 1.373–1.775, P < 1.0 × 10−9). This meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with RA susceptibility in different ethnic groups, especially in Europeans, and the PTPN22 C1858T polymorphism T allele is significantly more prevalent in RF-positive patents than in RF-negative patients.

[1]  Yu. V. Kudryashova,et al.  Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population , 2011, Aging.

[2]  Steven J. Schrodi,et al.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.

[3]  E. P. Teixiera,et al.  The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population , 2009, Annals of human biology.

[4]  B. Lie,et al.  Associations between the PTPN22 1858C→T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study , 2007, Annals of the rheumatic diseases.

[5]  Y H Lee,et al.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. , 2007, Rheumatology.

[6]  B. Franke,et al.  The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. , 2011, Arthritis and rheumatism.

[7]  M. Taniyama,et al.  The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. , 2005, Thyroid : official journal of the American Thyroid Association.

[8]  H. Rangel-Villalobos,et al.  The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico. , 2012, Immunology letters.

[9]  E. Eliopoulos,et al.  Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete , 2011, Lupus.

[10]  Sung-Hwan Park,et al.  Induction of Macrophage Migration Inhibitory Factor in ConA-Stimulated Rheumatoid Arthritis Synovial Fibroblasts through the P38 MAP Kinase-Dependent Signaling Pathway , 2010, The Korean journal of internal medicine.

[11]  A S Rigby,et al.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. , 2000, Arthritis and rheumatism.

[12]  C. Hengstenberg,et al.  Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls , 2009, Arthritis research & therapy.

[13]  Nunzio Bottini,et al.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.

[14]  S. Mastana,et al.  Association of PTPN22 with rheumatoid arthritis among South Asians in the UK. , 2007, The Journal of rheumatology.

[15]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[16]  Wendy Thomson,et al.  Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.

[17]  N. Inanç,et al.  No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey , 2009, Rheumatology International.

[18]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[19]  J. Harley,et al.  The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. , 2005, Arthritis and rheumatism.

[20]  A. Pawlik,et al.  PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy. , 2010, International immunopharmacology.

[21]  P. Gregersen,et al.  PTPN22: setting thresholds for autoimmunity. , 2006, Seminars in immunology.

[22]  S. Rantapää-Dahlqvist,et al.  Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden , 2007, Arthritis research & therapy.

[23]  Y. H. Lee,et al.  Genome scan meta-analysis of rheumatoid arthritis. , 2006, Rheumatology.

[24]  T. Merriman,et al.  Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. , 2005, Arthritis and rheumatism.

[25]  Javier Martín,et al.  Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[26]  J. Harley,et al.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis , 2005, Human Genetics.

[27]  A. Begovich,et al.  Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. , 2005, Arthritis and rheumatism.

[28]  C. Farrar,et al.  Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. , 2006, Rheumatology.

[29]  L. Diehl,et al.  PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells , 2004, Science.

[30]  Peter K Gregersen,et al.  Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. , 2009, Arthritis and rheumatism.

[31]  L. Nikitina-Zake,et al.  Association of protein tyrosine phosphatase non-receptor 22 (PTPN22) rs2476601 and Kruppel-like factor 12 (KLF12) rs1324913 single nucleotide polymorphisms with rheumatoid arthritis in a Latvian population , 2011, Scandinavian journal of rheumatology.

[32]  K. Siminovitch,et al.  Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. , 2005, Arthritis and rheumatism.

[33]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[34]  Jane Worthington,et al.  Extended Report , 2022 .

[35]  K. Siminovitch.  PTPN22 and autoimmune disease , 2004, Nature Genetics.

[36]  J. Anaya,et al.  PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases , 2005, Genes and Immunity.

[37]  E. Thorsby,et al.  The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. , 2007, Tissue antigens.

[38]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[39]  E. Karataylı,et al.  Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients. , 2011, Tissue antigens.

[40]  P. Gregersen.  Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond , 2005, Immunological reviews.

[41]  B. Lie,et al.  Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region , 2011, The Journal of Rheumatology.

[42]  Alice Mannocci,et al.  PTPN22 1858C>T Polymorphism Distribution in Europe and Association with Rheumatoid Arthritis: Case-Control Study and Meta-Analysis , 2011, PloS one.

[43]  J. Houwing-Duistermaat,et al.  Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population , 2011, Genes and Immunity.

[44]  A. Zhernakova,et al.  Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population , 2005, Genes and Immunity.

[45]  Y. Lee,et al.  Association of TNF-alpha –308 G/A polymorphism with responsiveness to TNF-α-blockers in rheumatoid arthritis: a meta-analysis , 2006, Rheumatology International.

[46]  S. Fisher,et al.  Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. , 2005, Arthritis and rheumatism.

[47]  S. Baudouin,et al.  A systematic review of the quality of genetic association studies in human sepsis , 2006, Intensive Care Medicine.

[48]  L. Czirják,et al.  Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects , 2009, Rheumatology International.

[49]  J. Tuomilehto,et al.  Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis , 2005, Genes and Immunity.